NOYES TIMOTHY P has filed 20 insider transactions across 1 company since January 2024.
Most recent transaction: a option exercise of 10000 shares of Jade Biosciences, Inc. ($JBIO) on May 16, 2024.
Activity breakdown: 0 open-market purchases and 11 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 16, 2024 | Jade Biosciences, Inc. | $JBIO | NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | M | Common Stock | 10000 | $2.14 | 10,000.0000 | 0 | 9999.99% | 0.00% |
| May 16, 2024 | Jade Biosciences, Inc. | $JBIO | NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | S | Common Stock | 8707 | $21.52 | 1,293.0000 | 0 | 87.07% | 0.00% |
| May 16, 2024 | Jade Biosciences, Inc. | $JBIO | NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | S | Common Stock | 1293 | $21.92 | 0.0000 | 0 | 100.00% | 0.00% |
| May 16, 2024 | Jade Biosciences, Inc. | $JBIO | NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | M | Stock Option (Right to Buy) | 10000 | $0.00 | 343,381.0000 | 0 | 2.83% | 0.00% |
| May 1, 2024 | Jade Biosciences, Inc. | $JBIO | NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | M | Common Stock | 10000 | $2.14 | 10,000.0000 | 0 | 9999.99% | 0.00% |
| May 1, 2024 | Jade Biosciences, Inc. | $JBIO | NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | S | Common Stock | 9035 | $20.34 | 965.0000 | 0 | 90.35% | 0.00% |
| May 1, 2024 | Jade Biosciences, Inc. | $JBIO | NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | S | Common Stock | 965 | $20.87 | 0.0000 | 0 | 100.00% | 0.00% |
| May 1, 2024 | Jade Biosciences, Inc. | $JBIO | NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | S | Common Stock | 1357 | $19.91 | 0.0000 | 0 | 100.00% | 0.00% |
| May 1, 2024 | Jade Biosciences, Inc. | $JBIO | NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | M | Stock Option (Right to Buy) | 10000 | $0.00 | 353,381.0000 | 0 | 2.75% | 0.00% |
| April 16, 2024 | Jade Biosciences, Inc. | $JBIO | NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | M | Common Stock | 10000 | $2.14 | 10,000.0000 | 0 | 9999.99% | 0.00% |
| April 16, 2024 | Jade Biosciences, Inc. | $JBIO | NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | S | Common Stock | 4491 | $24.40 | 5,509.0000 | 0 | 44.91% | 0.00% |
| April 16, 2024 | Jade Biosciences, Inc. | $JBIO | NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | S | Common Stock | 5509 | $24.94 | 0.0000 | 0 | 100.00% | 0.00% |
| April 16, 2024 | Jade Biosciences, Inc. | $JBIO | NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | M | Stock Option (Right to Buy) | 10000 | $0.00 | 363,381.0000 | 0 | 2.68% | 0.00% |
| April 1, 2024 | Jade Biosciences, Inc. | $JBIO | NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | M | Common Stock | 10000 | $2.14 | 10,000.0000 | 0 | 9999.99% | 0.00% |
| April 1, 2024 | Jade Biosciences, Inc. | $JBIO | NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | S | Common Stock | 4502 | $28.96 | 5,498.0000 | 0 | 45.02% | 0.00% |
| April 1, 2024 | Jade Biosciences, Inc. | $JBIO | NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | S | Common Stock | 1647 | $29.90 | 3,851.0000 | 0 | 29.96% | 0.00% |
| April 1, 2024 | Jade Biosciences, Inc. | $JBIO | NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | S | Common Stock | 2851 | $31.02 | 1,000.0000 | 0 | 74.03% | 0.00% |
| April 1, 2024 | Jade Biosciences, Inc. | $JBIO | NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | S | Common Stock | 1000 | $31.95 | 0.0000 | 0 | 100.00% | 0.00% |
| April 1, 2024 | Jade Biosciences, Inc. | $JBIO | NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | M | Stock Option (Right to Buy) | 10000 | $0.00 | 373,381.0000 | 0 | 2.61% | 0.00% |
| Jan. 29, 2024 | Jade Biosciences, Inc. | $JBIO | NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | A | Stock Option (Right to Buy) | 200000 | $0.00 | 200,000.0000 | 0 | 9999.99% | 0.00% |